Conference Report Location:HomeCPC MeetingConference ReportDetails

Report of the special session on basic research and clinical diagnosis and treatment of psoriasis in the third China psoriasis Congress

Source:China psoriasis Congress    Date:2019/10/27    Browse:1844 second

        The "special session on basic research and clinical diagnosis and treatment of psoriasis" was divided into two venues at the same time. Top experts from the field of psoriasis at home and abroad gave wonderful reports on the latest progress of psoriasis diagnosis and treatment.


        The first half of the session was co hosted by Professor Zhang Anping of the First Affiliated Hospital of Anhui Medical University and Professor Liu Shengxiu of the First Affiliated Hospital of Anhui Medical University Professor Mabuchi, Professor Yang Sen of the First Affiliated Hospital of Anhui Medical University, Professor Xu Jinhua, director of Dermatology, Huashan Hospital Affiliated to Fudan University, Professor Cui Yong, vice president of China Japan Friendship Hospital and Professor Jin Zhehu, President of the Affiliated Hospital of Yanbian University, respectively, presented the title "current treatment and clinical application of biological agents in psoriasis in China" The reports of "Japan", "yesterday, today and tomorrow of psoriasis treatment", "efficacy evaluation and toxicity detection and prevention of MTX treatment", "dynamic evaluation of psoriasis efficacy based on skin imaging" and "basic research and treatment progress of psoriasis" were reviewed from the history of psoriasis treatment at home and abroad, the application of biological agents in psoriasis, and the efficacy of psoriasis treatment drugs The latest research progress in the diagnosis and treatment of psoriasis was introduced in the aspects of prevention of side effects and application of skin imaging technology.






        The second half was jointly presided over by Professor Zhang Xuejun of the First Affiliated Hospital of Anhui Medical University, Professor Zong Wenkai of Dermatology Hospital of Chinese Academy of Medical Sciences and Professor Gao Min of the First Affiliated Hospital of Anhui Medical University. Professor Zhang Furen, vice president of Shandong First Medical University, Professor Xiao Shengxiang of the Second Affiliated Hospital of Xi'an Jiaotong University, and Professor Shen Zhu, director of Dermatology Department of Sichuan Provincial People's Hospital, gathered respectively Focusing on the treatment of difficult and severe psoriasis, examining the research and treatment of psoriasis from the development history of modern medicine, and the intestinal flora and chronic psoriasis management, Jiao shared his experience of medication with you around the drug action mechanism and clinical application types. Professor Lu Yonghong, director of Dermatology Department of Chengdu Second People's Hospital, Professor Chen Min of Dermatology Hospital of Chinese Academy of Medical Sciences, and Professor Qiu Ying, director of Dermatology Department of Jining first people's Hospital, respectively brought "problems and Countermeasures in the treatment of psoriasis", "individualized experience in the application of biological agents for psoriasis", "2018" According to the expert consensus on the assessment and local treatment management of mild to moderate plaque psoriasis in Asia, Professor Shi Yuling, vice president of Shanghai Dermatology Hospital, brought "IL12 / 23" to Xi'an YANGSEN satellite conference Each professor shared with the participants the problems and solutions for different types of psoriasis and different treatment methods in their clinical work, and carried out one by one in the form of typical case analysis, covering a wide range of contents and close to the clinical application, with warm applause from time to time.








        In the second session, Professor Zhang Xuejun, the First Affiliated Hospital of Anhui Medical University, Cui pangen, Professor Wang Peiguang of the First Affiliated Hospital of Chinese Academy of Medical Sciences and Professor Zheng Min of the Second Affiliated Hospital of Zhejiang University and Professor Li Yuzhen, director of Dermatology Department of the Second Affiliated Hospital of Harbin Medical University, jointly presided over by Professor Zhang Xuejun, the First Affiliated Hospital of Anhui Medical University, and Professor Wang Peiguang of the First Affiliated Hospital of Anhui Medical University Professor Zhang Chunlei, director of Dermatology, the Third Hospital of Peking University, Professor Li Fuqiu, director of Dermatology, Second Hospital of Jilin University, Professor Wang Honglin, deputy director of Shanghai Institute of immunology, and Professor Lv Chengzhi, vice president of Dalian skin disease hospital, respectively, presented the following topics: "IL-8 past and present life", "early attention to joint psoriasis", "biological agents in Chinese people's psoriasis" The reports of RCT and we research of psoriasis, past, present and future of psoriasis treatment, basic and translational medicine research of psoriasis, and new goals of psoriasis treatment were introduced. It mainly introduced the new progress of basic research and clinical transformation of psoriasis, diagnosis and treatment of arthritic psoriasis and the application status of biological agents in psoriasis, emphasizing the rapid and efficient control of dermatitis At present, psoriasis or skin lesions are the target of psoriasis treatment, and clinical management should be strengthened at the same time.







        The second half of the session was jointly presided over by Professor Xiao Fengli of the First Affiliated Hospital of Anhui Medical University, Professor Chen Min of Dermatology Hospital of Chinese Academy of Medical Sciences and Professor Fan Xing of the First Affiliated Hospital of Anhui Medical University. Professor Sun Qiuning of Peking Union Medical College, Professor Lu Qianjin, director of Dermatology, Xiangya Second Medical College of Central South University, Professor Lu Yan, director of Dermatology Department of Jiangsu Provincial People's Hospital, were jointly presided over by Professor Sun Qiuning of Peking Union Medical College, Professor Lu Qianjin, director of Dermatology, Xiangya Second Professor Zheng Yan of the Second Affiliated Hospital of Xi'an Jiaotong University, Professor Xu Zhe of Beijing Children's Hospital Affiliated to Capital Medical University and Professor Ji Chao of the First Affiliated Hospital of Fujian Medical University respectively shared "the role of dermatoscopy in the evaluation of severity and efficacy of psoriasis with PASI score", "Research on epigenetic regulation mechanism and its transformation medicine of psoriasis", "severe psoriasis" The reports on the treatment of psoriasis, clinical manifestations and treatment of psoriatic arthritis, diagnosis and treatment of pustular psoriasis in children, and the application of biological agents in the treatment of psoriasis in China were reported, including the epigenetic research of psoriasis, the prospect of dermatoscopic diagnosis and the treatment of special psoriasis.







        At the end of the meeting, Professor Zhang Xuejun, chairman of the psoriasis professional committee of Dermatology and Venereology branch of Chinese Medical Association, commented and summarized. Professor Zhang pointed out that the wonderful reports presented by experts today focused on the frontier, based on the foundation, close to the clinical practice, with wide coverage, large amount of information and strong professionalism, covering basic research, artificial intelligence diagnosis, traditional drugs and other aspects of psoriasis The clinical experience sharing of new drug treatment, precise treatment of biological agents and combination of traditional Chinese and Western medicine diagnosis and treatment, etc. It is hoped that the academic conference can spread knowledge and share information, improve the diagnosis and treatment level of domestic dermatologists, promote the further development of psoriasis prevention and treatment in China, and ultimately benefit the majority of psoriasis patients.

China Psoriasis Network CPC2020

Xu Xiangmei (Conference consultation)
Mobile:15005604686
Email:1225856963@qq.com
Zhu Xiaofeng (Registration consulting)
Mobile:15156991066
Email:307676249@qq.com

Copyright: China Psoriasis Network Wanicp Bei 11019793 皖公网安备 34019202000792号